Therefore, individuals suffering from obesity, diabetes, and related metabolic disorders also present with highly elevated LBP-levels (29–31), which was probably attributed to chronic low-grade inflammation induced by alterations of the intestinal flora together with an increased gut permeability to LPS (32, 33). Here, LBP is linked to metabolic disease.